Crystalline forms of nonprotein drugs filed in Brazil from 1995–2005

Author:

Lira Luiz Marcelo1,da Silva Luiz Cláudio Rodrigues Pereira2,Ribeiro Antônio J3,Veiga Francisco3,Rodrigues Carlos Rangel2,do Carmo Flávia Almada2,de Sousa Valéria Pereira2,Cabral Lúcio Mendes2

Affiliation:

1. Laboratório de Tecnologia Industrial Farmacêutica (LabTIF), Departamento de Medicamentos, Avenida Carlos Chagas Filho, 373, CCS, Bloco Lss, sala 20, Cidade Universitária. CEP: 21941902, Rio de Janeiro, Universidade Federal do Rio de Janeiro (UFRJ), Brazil.

2. Laboratório de Tecnologia Industrial Farmacêutica (LabTIF), Departamento de Medicamentos, Avenida Carlos Chagas Filho, 373, CCS, Bloco Lss, sala 20, Cidade Universitária. CEP: 21941902, Rio de Janeiro, Universidade Federal do Rio de Janeiro (UFRJ), Brazil

3. Faculdade de Farmácia, Pólo das Ciências da Saúde, Pólo III, Azinhaga de Santa Comba, CEP: 3000-548, CoimbraUniversidade de Coimbra, Portugal

Abstract

In the present study, we evaluated 457 patent applications filed for crystalline forms of nonprotein drugs during the period 1995–2005 in Brazil. Online searches were conducted using the Instituto Nacional da Propriedade Industrial patent database and the Derwent Innovations Index®. It was found that no patent applications in this area were filed by Brazilian applicants. It was also noted that only 61% of patent applications included the characterization of three or more crystalline phase techniques. In most applications, no determination of purity was provided for chemical and/or crystalline phases. In a subset of patent applications, those for blockbuster drugs, we found that approximately 90% did not meet Instituto Nacional da Propriedade Industrial acceptance criteria nor the criteria developed in this study. These results reveal that appropriate and thorough characterization of the crystalline forms of drugs is, indeed, lacking in patent applications.

Publisher

Future Science Ltd

Subject

General Medicine

Reference55 articles.

1. ArrudaGF, Cerdeira PC. Patentes farmacêuticas e saúde pública. In:Propriedade Intelectual- Novos Paradigmas Internacionais, Conflitos e Desafios. Elsevier

2. Amsterdam, The Netherlands,117–152 (2007).

3. Proteção Patentária e Inovação nas Indústrias Farmacêuticas: Os mecanismos do Evergreening e as alternativas dos Fair Followers. Anais do XVII Congresso Nacional do CONPEDI, Brasília, 6309–6336.www.conpedi.org.br/manaus/arquivos/anais/brasilia/02_436.pdf

4. The art of using secondary patents to improve protection

5. CorreaCM.Guidelines for the Examination of Pharmaceutical Patents: Developing a Public Health Perspective. World Health Organization, International Centre for Trade and Sustainable Development, UN Conference on Trade and Development, Geneva, Switzerland (2007).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3